Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This study is a Randomized, Double-Blind, Placebo-Controlled Trial. The objective of the
study is to assess the effect of doxycycline in levodopa treated Parkinson's disease patients
regarding motor performance and cognitive functions. Parkinson's disease patients on levodopa
medications will be assigned to receive doxycycline 50mg twice daily or placebo over 8 weeks.
The motor and cognitive symptoms of Parkinson's disease will be assessed after 4 weeks and 8
weeks follow up.
Phase:
Phase 2
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh